Insulin resistance after precocious pubarche: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gain. (Q47284737)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 June 2007

Language	Label	Description	Also known as
English	Insulin resistance after precocious pubarche: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gain.	scientific article published on 7 June 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Insulin resistance after precocious pubarche: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gain (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

David B. Dunger

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Lourdes Ibañez

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Francis de Zegher

7

object named as

Francis de Zegher

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Abel López-Bermejo

1

object named as

Abel López-Bermejo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Paula Casano-Sancho

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Adriana M Jaramillo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Francesc-Xavier Rodríguez-González

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

7 June 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Clinical Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

67

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

493-499

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Birth weight and the insulin resistance syndrome: association of low birth weight with truncal obesity and raised plasminogen activator inhibitor-1 but not with abdominal obesity or plasma lipid disturbances

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

The common -675 4G/5G polymorphism in the plasminogen activator inhibitor -1 gene is strongly associated with obesity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Plasminogen activator inhibitor genotype and brain infarction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Plasminogen-activator inhibitor-1 polymorphisms are associated with obesity and fat distribution in the Quebec Family Study: evidence of interactions with menopause.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Prediction of the risk of myocardial infarction from polymorphisms in candidate genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

The plasminogen activator system in young and lean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02914.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2007.02914.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555513%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47284737&oldid=1846299081"